Omya International will be moving its research and development activities to Egerkingen after the acquisition of the Galderma-Spirig site. The buildings in Egerkingen have a modern…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
